Literature DB >> 11172010

ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response.

S Peretz1, R Jensen, R Baserga, P M Glazer.   

Abstract

The ATM gene is mutated in the syndrome of ataxia telangiectasia (AT), associated with neurologic dysfunction, growth abnormalities, and extreme radiosensitivity. Insulin-like growth factor-I receptor (IGF-IR) is a cell surface receptor with tyrosine kinase activity that can mediate mitogenesis, cell transformation, and inhibition of apoptosis. We report here that AT cells express low levels of IGF-IR and show decreased IGF-IR promoter activity compared with wild-type cells. Complementation of AT cells with the ATM cDNA results in increased IGF-IR promoter activity and elevated IGF-IR levels, whereas expression in wild-type cells of a dominant negative fragment of ATM specifically reduces IGF-IR expression, results consistent with a role for ATM in regulating IGF-IR expression at the level of transcription. When expression of IGF-IR cDNA is forced in AT cells via a heterologous viral promoter, near normal radioresistance is conferred on the cells. Conversely, in ATM cells complemented with the ATM cDNA, specific inhibition of the IGF-IR pathway prevents correction of the radiosensitivity. Taken together, these results establish a fundamental link between ATM function and IGF-IR expression and suggest that reduced expression of IGF-IR contributes to the radiosensitivity of AT cells. In addition, because IGF-I plays a major role in human growth and metabolism and serves as a survival and differentiation factor for developing neuronal tissue, these results may provide a basis for understanding other aspects of the AT syndrome, including the growth abnormalities, insulin resistance, and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172010      PMCID: PMC29316          DOI: 10.1073/pnas.98.4.1676

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  ATM: a mediator of multiple responses to genotoxic stress.

Authors:  G Rotman; Y Shiloh
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

2.  Growth of cultured cells from patients with ataxia-telangiectasia.

Authors:  E Elmore; M Swift
Journal:  J Cell Physiol       Date:  1976-11       Impact factor: 6.384

Review 3.  The IGF-I receptor in cancer research.

Authors:  R Baserga
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

4.  Colony-forming ability of ataxia-telangiectasia skin fibroblasts is an indicator of their early senescence and increased demand for growth factors.

Authors:  Y Shiloh; E Tabor; Y Becker
Journal:  Exp Cell Res       Date:  1982-07       Impact factor: 3.905

5.  Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis.

Authors:  F Peruzzi; M Prisco; M Dews; P Salomoni; E Grassilli; G Romano; B Calabretta; R Baserga
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Authors:  S Banin; L Moyal; S Shieh; Y Taya; C W Anderson; L Chessa; N I Smorodinsky; C Prives; Y Reiss; Y Shiloh; Y Ziv
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

Review 7.  ATM: from gene to function.

Authors:  G Rotman; Y Shiloh
Journal:  Hum Mol Genet       Date:  1998       Impact factor: 6.150

8.  Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells.

Authors:  A Morrione; G Romano; M Navarro; K Reiss; B Valentinis; M Dews; E Eves; M R Rosner; R Baserga
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

9.  Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors.

Authors:  R S Bar; W R Levis; M M Rechler; L C Harrison; C Siebert; J Podskalny; J Roth; M Muggeo
Journal:  N Engl J Med       Date:  1978-05-25       Impact factor: 91.245

10.  An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells.

Authors:  N Zhang; P Chen; M Gatei; S Scott; K K Khanna; M F Lavin
Journal:  Oncogene       Date:  1998-08-20       Impact factor: 9.867

View more
  47 in total

1.  Ataxia telangiectasia mutated kinase deficiency impairs the autophagic response early during myocardial infarction.

Authors:  Patsy R Thrasher; Stephanie L C Scofield; Suman Dalal; Claire C Crawford; Mahipal Singh; Krishna Singh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-13       Impact factor: 4.733

2.  ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.

Authors:  Naoe Taira; Hiroyuki Yamamoto; Tomoko Yamaguchi; Yoshio Miki; Kiyotsugu Yoshida
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

Review 3.  ATM protein kinase: the linchpin of cellular defenses to stress.

Authors:  Shahzad Bhatti; Sergei Kozlov; Ammad Ahmad Farooqi; Ali Naqi; Martin Lavin; Kum Kum Khanna
Journal:  Cell Mol Life Sci       Date:  2011-05-02       Impact factor: 9.261

Review 4.  DNA double-strand break - induced pro-survival signaling.

Authors:  Amy J Hawkins; Sarah E Golding; Ashraf Khalil; Kristoffer Valerie
Journal:  Radiother Oncol       Date:  2011-07-02       Impact factor: 6.280

5.  Therapeutic destruction of insulin receptor substrates for cancer treatment.

Authors:  Hadas Reuveni; Efrat Flashner-Abramson; Lilach Steiner; Kirill Makedonski; Renduo Song; Alexei Shir; Meenhard Herlyn; Menashe Bar-Eli; Alexander Levitzki
Journal:  Cancer Res       Date:  2013-05-07       Impact factor: 12.701

6.  LINCS gene expression signature analysis revealed bosutinib as a radiosensitizer of breast cancer cells by targeting eIF4G1.

Authors:  Sai Hu; Dafei Xie; Pingkun Zhou; Xiaodan Liu; Xiaoyao Yin; Bo Huang; Hua Guan
Journal:  Int J Mol Med       Date:  2021-03-11       Impact factor: 4.101

7.  Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer.

Authors:  Jinliang Xing; Xifeng Wu; Ara A Vaporciyan; Margaret R Spitz; Jian Gu
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

8.  Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination.

Authors:  Joanna Trojanek; Thu Ho; Luis Del Valle; Michal Nowicki; Jin Ying Wang; Adam Lassak; Francesca Peruzzi; Kamel Khalili; Tomasz Skorski; Krzysztof Reiss
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 9.  Receptor signaling as a regulatory mechanism of DNA repair.

Authors:  Raymond E Meyn; Anapama Munshi; John V Haymach; Luka Milas; K Kian Ang
Journal:  Radiother Oncol       Date:  2009-07-15       Impact factor: 6.280

Review 10.  Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors:  Rongshi Li; Alan Pourpak; Stephan W Morris
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.